Comparison of low dose and high dose of furazolidone in the treatment of Helicobacter pylori infection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160118026097N6

Enrollment

170

Registered

2021-05-11

Start date

2015-07-23

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacterpylori Eradication. Gastric ulcer

Interventions

Intervention 1: Intervention group 1: After obtaining informed consent and full explanation of the treatment process to the patient and his companions regarding the treatment process, under low-dose f

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Peptic ulcer diagnosis with endoscopic diagnosis test Helicobacter pylori infection with RUT consent to cooperate

Exclusion criteria

Exclusion criteria: Pregnancy Cancer or Liver Failure Diabetes Mellitus History of Cigarette History of Alcohol History of Drug Sensitivity

Design outcomes

Primary

Measure	Time frame
Response to treatment-Helicobacter pylori eradication after drug treatment with urease respiratory test. Timepoint: Six weeks after drug treatment. Method of measurement: Urease Respiratory Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactjamshid vafaeemanesh

Ghoum University of Medical Sciences

jvafaeemanesh@gmail.com+98 25 3612 2526

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026